For Research and Laboratory Use Only
27% OFFGLOW is a proprietary peptide blend combining GHK-Cu, BPC-157, and TB-500. Designed for comprehensive tissue and skin biology research. 70mg total blend per vial, 99% HPLC verified purity.
$149.99
$109.99
HPLC tested >99%
Fri, Apr 17 – Sun, Apr 19
For research and laboratory use only. Not for human consumption, therapeutic, or diagnostic use. Must be 21+ to purchase.
PATHWAYS
VEGF + Actin + Collagen synergy
GHR UPREGULATION
BPC-157 by day 3
COLLAGEN INCREASE
GHK-Cu vs controls
FASTER HEALING
TB-500 re-epithelialization
COMBINED STUDIES
Across all three peptides
MECHANISM OF ACTION
GLOW combines three well-researched peptides that target distinct but complementary regenerative mechanisms. BPC-157 promotes angiogenesis, TB-500 enhances cell migration, and GHK-Cu stimulates collagen synthesis.
Vascular Endothelial Growth Factor (BPC-157)
Thymosin Beta-4 Pathway (TB-500)
From clinical studies and research protocols
Standard research doses for each peptide based on published literature
200-500mcg
1-2x daily, standard preclinical range
2-5mg
2x weekly, loading then maintenance
1-2mg
Daily, GHK-Cu topical or injection
PHARMACOKINETICS
Each component has different stability and PK profiles
Combination may require special formulation considerations
SAFETY PROFILE
FAQ
GLOW is a triple-peptide blend containing BPC-157 (15-amino acid gastric peptide), TB-500 (43-amino acid thymosin beta-4 fragment), and GHK-Cu (copper tripeptide). Each targets different but complementary regenerative mechanisms.
·This is a research compound combination not approved for human use
·Component ratios in commercial blends may vary
·Consult published literature for specific research applications
·All three peptides have different regulatory statuses
Copper Peptide Signaling (GHK-Cu)
CLINICAL / RESEARCH RESULTS
Data aggregated from individual peptide studies in animal models. BPC-157: 200+ studies, TB-500: 170+ studies, GHK-Cu: 130+ studies.
9x
Collagen in wounds
GHK-Cu with PIC treatment
7x
GHR upregulation by day 3
BPC-157 in tendon fibroblasts
61%
Faster re-epithelialization
TB-500 vs controls at 7 days
RESEARCH APPLICATIONS
GHK-Cu promotes collagen synthesis, while BPC-157 and TB-500 support epithelial repair and reduce scarring.
Source: Pickart & Margolina 2018
TB-500 facilitates actin remodeling; BPC-157 promotes tendon fibroblast viability; GHK-Cu supports vascular stabilization.
Source: Chi et al. 2017
All three peptides demonstrate anti-inflammatory properties through different mechanisms in animal models.
Source: Hsieh et al. 2016
Coordinated extracellular matrix deposition and degradation for functional, less fibrotic tissue regeneration.
Source: Brcic et al. 2011
·Doses from individual peptide studies, not combination protocols
·Actual blend ratios may vary by manufacturer
·Research protocols should be designed based on specific models
Store lyophilized powder at -20°C for long-term stability
·All three peptides are research compounds with varying regulatory status
·GHK-Cu has the longest history of safe use (in cosmetics)
·Combination products require additional safety characterization
COMPOUND INFORMATION
Lyophilized (powder)
Reconstituted
Light protection
